$0.17

(%)
Live
Previous Close

$0.1676

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

New York Stock Exchange

...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering. Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 80.1% to $5.80. Palisade Bio announced $2.5 million registered direct offering and concurrent private placement priced above market under Nasdaq rules. Silo Pharma, Inc. (NASDAQ: SILO) gained 63.7% to $5.60 after the company announced study results of SPU-21 for arthritis. The company said SPU-21 is effective in controlling arthritis progression. F-star Therapeutics, Inc. (NASDAQ: FSTX) shares gained 42.8% to $5.84. F-Star Therapeutics shares traded lower on Thursday after the Committee on Foreign Investment issued an interim order preventing the closing of the pending merger with Invox Pharma. Kala Pharmaceuticals, Inc. (NASDAQ: KALA) jumped 38% to $33.65. Kala Pharmaceuticals recently announced FDA acceptance of an IND application for its KPI-012 for the treatment of persistent corneal epithelial defect. Charah Solutions, Inc. (NYSE: CHRA) gained 37.6% to $5.57. Charah Solutions reported receipt of notification letter from NYSE. Embark Technology, Inc. (NASDAQ: EMBK) gained 33% to $3.4686. NovaBay Pharmaceuticals, Inc. (NYSE: NBY) jumped 27.3% to $1.77. Allarity Therapeutics, Inc. (NASDAQ: ALLR) jumped 26.7% to $0.3679. Concord Medical Services Holdings Limited (NYSE: CCM) gained 23.8% to $1.6599. Mereo BioPharma Group plc (NASDAQ: MREO) surged 23.6% to $0.69. 9 Meters Biopharma, Inc. (NASDAQ: NMTR) gained 23% to $1.4450. Frequency Therapeutics, Inc. (NASDAQ: FREQ) jumped 22.5% to $3.97. Journey Medical Corporation (NASDAQ: DERM) surged 22% to $1.77. Journey Medical recently announced PK comparability data of DFD-29 and key updates on the progress of ...

Related tickers: HSTO, DERM, SILO, DS, FSTX, NBY, FUTU, ZEV, NILE, KALA, PALI, PTIX, SECO, TUEM, TIGR, RSLS, EZGO, RCI, BLNK, RNAZ, SJR, SRRK, UNCY, SCLX, RUBY, DRMA, CCM, SESN, SISI, NAVB, CHRA, ALLR, ECX, LEV, EMBK, SLRX, SXTC, NAAS, MREO, HOTH, GETR, AXDX, FREQ, KA, QTNT, NMTR.

Read Full Article

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share. Core Scientific, Inc. (NASDAQ: CORZ) rose 65% to $0.4125. B. Riley Financial issued an open letter to Core Scientific shareholders and lenders. Scopus BioPharma Inc. (NASDAQ: SCPS) shares jumped 58.1% to $0.3711 after declining 4% on Wednesday. Icosavax, Inc. (NASDAQ: ICVX) shares climbed 42.9% to $12.75. Icosavax shares jumped 112% on Wednesday after the company provided a six-month immunogenicity update from its Phase 1/1b trial of IVX-121 against respiratory syncytial virus IMV Inc. (NASDAQ: IMV) surged 34.4% to $2.89 after the company announced initial data from the ongoing Phase 2B VITALIZE trial in patients with r/r DLBCL. Clearmind Medicine Inc. (NASDAQ: CMND) shares jumped 22.3% to $3.8898. Clearmind Medicine’s CEO, Dr. Adi Zuloff-Shani, issued a letter to shareholders. Kintara Therapeutics, Inc. (NASDAQ: KTRA) rose 18.8% to $9.52. Kintara Therapeutics received orphan drug designation for VAL-083 for treatment of diffuse intrinsic pontine glioma. Lanvin Group Holdings Ltd. (NYSE: LANV) gained 18% to $11.75. Iterum Therapeutics plc (NASDAQ: ITRM) surged 18% to $1.34 after the company announced issuance of allowance for a U.S. patent covering oral sulopenem. Troika Media Group, Inc. (NASDAQ: TRKA) gained 17% to $0.12. Astria Therapeutics, Inc. (NASDAQ: ATXS) rose 15.8% to $12.76. Astria Therapeutics announced preliminary results from the Phase 1a trial of STAR-0215 in healthy subjects. Steakholder Foods Ltd. (NASDAQ: STKH) rose 15% to $0.89. Rallybio Corporation (NASDAQ: RLYB) surged 14.1% to $7.20. Rallybio announced publication of data highlighting the ability of HPA-1a-specific antibodies ...

Related tickers: ICVX, HUYA, RLYB, ITRM, INDP, AGYS, ALIT, SRZN, NVAX, AXLA, ATXS, RICK, CRKN, CORZ, SHBI, KTRA, STKH, THRD, ELYS, MLGO, IMV, SIOX, RBLX, GLYC, PBLA, BIMI, WNW, DS, SCPS, NH, VLON, CKPT, TRKA, CVNA, VERV, APRN, MIRO, CMND.

Read Full Article
Trending Tickers

Please sign in to view